A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting
Condition: Vaginal AtrophyInterventions: Drug: estriol; Drug: PlaceboSponsors: ITF Research Pharma, S.L.U.; Spanish Breast Cancer Research GroupRecruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Aci-Jel | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Hormones | Pharmaceuticals | Research | Women